Results 31 to 40 of about 1,006,426 (373)

Extracorporeal liver assist device to exchange albumin and remove endotoxin in acute liver failure: Results of a pivotal pre-clinical study [PDF]

, 2015
Background & AimsIn acute liver failure, severity of liver injury and clinical progression of disease are in part consequent upon activation of the innate immune system.
Aggarwal, Antoine, B. Kevin Park, Banares, Banwari Agarwal, Carolina Jimenez Palacios, Christopher E. Goldring, Daniel J. Antoine, D’Souza, Fausto Andreola, Fisher, Garcia-Martinez, Giacomo Stanzani, Hatim Alibhai, Honore, Imaeda, Jaeschke, Jalan, Jalan, Karla C.L. Lee, Kribben, Lee, Lee, Liu, Lu, Luisa A. Baker, Maher, Martin-Murphy, Millis, Mookerjee, Morgera, Morgera, Morgera, Morgera, Morgera, Nathan A. Davies, Nystrom, Oettl, Oettl, Pamela J. Leckie, Paola Giordano, Rademacher, Rajeshwar P. Mookerjee, Rajiv Jalan, Rifai, Rimmele, Rosalind E. Jenkins, Saliba, Scaffidi, Sen, Shah, Simon L. Priestnall, Simpson, Stadlbauer, Su, Su, Szabo, Vaquero, Venereau, Yang, Yu Mei Chang, Yumoto   +61 more
core   +1 more source

Acute Liver Failure [PDF]

Clinical Medicine, 2015
Acute liver failure is a rare but potentially fatal disease. Adult definition of fulminant hepatic failure, which includes the development of hepatic necrosis and encephalopathy within 8 weeks of onset of liver disease does not apply to acute liver failure in children particularly if secondary to autoimmune or metabolic liver disease.
Laura, Blackmore, William, Bernal
openaire   +4 more sources

The Comparison of LightGBM and XGBoost Coupling Factor Analysis and Prediagnosis of Acute Liver Failure

IEEE Access, 2020
This paper focuses on the comparison of dimensionality reduction effect between LightGBM and XGBoost-FA. With respect to XGBoost, LightGBM can be built in the effect of dimensionality reduction via both Gradient-based One-Side Sampling(GOSS) and ...
Dongyang Zhang, Yicheng Gong
semanticscholar   +1 more source

Early Acute Liver Failure in Severe Acute Hepatitis B [PDF]

, 2002
Early acute liver failure is defined by the presence of a drop below 50% of the normal prothrombine ratio, jaundice, and clotting factors of less than 50% in any patient with acute liver disease.
Siregar, G. A. (Gontar)
core   +1 more source

The association between FABP7 serum levels with survival and neurological complications in acetaminophen-induced acute liver failure: a nested case–control study

Annals of Intensive Care, 2017
Background Acetaminophen (APAP)-induced acute liver failure (ALF) is associated with significant mortality due to intracranial hypertension (ICH), a result of cerebral edema (CE) and astrocyte swelling.
Constantine J. Karvellas, Jaime L. Speiser, Mélanie Tremblay, William M. Lee, Christopher F. Rose, For the US Acute Liver Failure Study Group   +5 more
doaj   +1 more source

Acute liver failure due to herpes simplex viral hepatitis diagnosed by skin lesions and blood tests: a case report

Journal of Medical Case Reports, 2023
Background The incidence of acute liver failure from herpes simplex virus is rare. Case presentation A 71-year-old Japanese man was diagnosed with acute liver failure and was transferred to our hospital.
Kento Shionoya, Makoto Kako, Sakue Masuda, Makomo Makazu, Kazuya Koizumi   +4 more
doaj   +1 more source

Acute liver failure is regulated by MYC- and microbiome-dependent programs

Nature Network Boston, 2020
Acute liver failure (ALF) is a fulminant complication of multiple etiologies, characterized by rapid hepatic destruction, multi-organ failure and mortality. ALF treatment is mainly limited to supportive care and liver transplantation. Here we utilize the
Aleksandra A. Kolodziejczyk, Sara Federici, N. Zmora, Gayatree Mohapatra, Mally Dori-Bachash, Shanni Hornstein, Avner Leshem, Debby Reuveni, E. Zigmond, A. Tobar, T. Salame, A. Harmelin, A. Shlomai, H. Shapiro, I. Amit, E. Elinav   +15 more
semanticscholar   +1 more source

Applications of Nanobiomaterials in the Therapy and Imaging of Acute Liver Failure

Nano-Micro Letters, 2020
This review focuses on the therapeutic mechanisms, targeting strategies of various nanomaterials in acute liver failure, and recent advances of diverse nanomaterials for acute liver failure therapy, diagnosis, and imaging. This review provides an outlook
Yuanyuan Jin, Haixia Wang, Ke Yi, Shixian Lv, Hanze Hu, Mingqiang Li, Yu Tao   +6 more
semanticscholar   +1 more source

Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute‐on‐chronic liver failure

Liver international (Print), 2021
Understanding factors responsible for the increased bleeding tendency in acute‐on‐chronic liver failure (ACLF) would improve the management of these complications.
E. Campello, A. Zanetto, C. Bulato, S. Maggiolo, L. Spiezia, F. Russo, S. Gavasso, P. Mazzeo, D. Tormene, P. Burra, P. Angeli, M. Senzolo, P. Simioni   +12 more
semanticscholar   +1 more source

Brain edema in acute liver failure and chronic liver disease: Similarities and differences [PDF]

, 2013
Hepatic encephalopathy (HE) is a complex neuropsychiatric syndrome that typically develops as a result of acute liver failure or chronic liver disease. Brain edema is a common feature associated with HE. In acute liver failure, brain edema contributes to
Bosoi, Cristina R., Rose, Christopher
core   +1 more source